Literature DB >> 29746931

CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway.

Yuan-Yuan Zhang1, Ling-Qun Kong2, Xiao-Dong Zhu1, Hao Cai1, Cheng-Hao Wang3, Wen-Kai Shi1, Man-Qing Cao1, Xiao-Long Li1, Kang-Shuai Li1, Shi-Zhe Zhang1, Zong-Tao Chai4, Jian-Yang Ao5, Bo-Gen Ye6, Hui-Chuan Sun7.   

Abstract

Platelet endothelial cell adhesion molecule-1 (PECAM-1 or CD31) is a well-known marker of endothelial cells and a key factor for adhesion and accumulation of platelets. CD31 plays roles in cell proliferation, apoptosis, migration, and cellular immunity. CD31 is also expressed on tumor cells, such as breast cancer cells and non-Hodgkin's lymphomas, and contributes to tumor cell invasion. Here, our experiments show that CD31 promotes metastasis by inducing the epithelial-mesenchymal transition in hepatocellular carcinoma by up-regulating integrin β1 via the FAK/Akt signaling pathway.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD31; Epithelial–mesenchymal transition; Hepatocellular carcinoma; Integrin β1; PECAM-1

Mesh:

Substances:

Year:  2018        PMID: 29746931     DOI: 10.1016/j.canlet.2018.05.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

1.  Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway.

Authors:  Ning Wang; Li-Li Chang
Journal:  Hum Cell       Date:  2020-05-14       Impact factor: 4.174

Review 2.  Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer.

Authors:  Abirami Arunachalam; Dinesh Kumar Lakshmanan; Guna Ravichandran; Soumi Paul; Sivakumar Manickam; Palanirajan Vijayaraj Kumar; Sivasudha Thilagar
Journal:  Med Oncol       Date:  2021-09-04       Impact factor: 3.064

3.  MCRS1 Expression Regulates Tumor Activity and Affects Survival Probability of Patients with Gastric Cancer.

Authors:  Liang-Han Wang; Chih-Chun Chang; Chiao-Yin Cheng; Yao-Jen Liang; Dee Pei; Jen-Tang Sun; Yen-Lin Chen
Journal:  Diagnostics (Basel)       Date:  2022-06-20

4.  Modified Thymosin Alpha 1 Distributes and Inhibits the Growth of Lung Cancer in Vivo.

Authors:  Renhao Peng; Caoying Xu; Heng Zheng; Xingzhen Lao
Journal:  ACS Omega       Date:  2020-04-27

5.  NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.

Authors:  Kang-Shuai Li; Xiao-Dong Zhu; Hong-Da Liu; Shi-Zhe Zhang; Xiao-Long Li; Nan Xiao; Xue-Feng Liu; Bin Xu; Ming Lei; Yuan-Yuan Zhang; Wen-Kai Shi; Man-Qing Cao; Yun-Fei Xu; Zhao-You Tang; Hui-Chuan Sun
Journal:  Cell Death Dis       Date:  2020-05-07       Impact factor: 8.469

6.  Combination Therapy of Prostate Cancer by Oncolytic Adenovirus Harboring Interleukin 24 and Ionizing Radiation.

Authors:  Li-Jun Mao; Yi Kan; Bing-Heng Li; Sai Ma; Yirui Liu; Dong-Liang Yang; Chunhua Yang
Journal:  Front Oncol       Date:  2020-04-03       Impact factor: 6.244

7.  Matrine suppresses breast cancer metastasis by targeting ITGB1 and inhibiting epithelial-to-mesenchymal transition.

Authors:  Lili Ren; Wenju Mo; Linling Wang; Xiaojia Wang
Journal:  Exp Ther Med       Date:  2019-11-18       Impact factor: 2.447

8.  Primary undifferentiated pleomorphic sarcoma in oral-maxillary area: retrospective study and molecular analysis.

Authors:  Yuanhe You; Rongxin Shi; Meilu Dai; Zhong Du; Zhuowei Tian; Guisong Xu; Lizhen Wang; Yan'an Wang; Meng Xiao
Journal:  Histol Histopathol       Date:  2021-07-20       Impact factor: 2.303

9.  Adipose matrix complex: a high-rigidity collagen-rich adipose-derived material for fat grafting.

Authors:  Ye Li; Pan Zhang; Xue Zhang; Xin Bi; Mengfan Wu; Jialiang Zou; Zijue Wang; Feng Lu; Ziqing Dong; Jianhua Gao
Journal:  Aging (Albany NY)       Date:  2021-06-09       Impact factor: 5.682

10.  VEGF promotes migration and invasion by regulating EMT and MMPs in nasopharyngeal carcinoma.

Authors:  Li Chen; Guoxiang Lin; Kaihua Chen; Renba Liang; Fangzhu Wan; Chuxiao Zhang; Ge Tian; Xiaodong Zhu
Journal:  J Cancer       Date:  2020-10-21       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.